So far, we have provided data supporting the association of the VDAC1P8 pseudogene with AML as well as a suitable detection method to distinguish it from its parental gene VDAC1. This lays the foundation for its possible use as a biomarker for AML. Here, VDAC1 is linked to acute myeloid leukemia.